Trial Profile
Phase III Open Study of BAY 77 1931 (Lanthanum Carbonate) in Patients With Hyperphosphatemia Undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Lanthanum carbonate (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Sponsors Bayer
- 08 Apr 2015 New trial record